CAI (STOCKS)
Caris Life Sciences, Inc. Common Stock
$19.000000
+0.950000 (+5.26%)
Prev close: $18.050000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David Dean Halbert
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,408.58M
- Employees
- 1,846
- P/E (TTM)
- -9.99
- P/B (TTM)
- 9.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.28 | $0.03 | +0.2481 | +777.74% |
|
Sep 2025 (Q3)
|
$0.08 | $-0.21 | +0.2941 | +138.66% |
|
Jun 2025 (Q2)
|
$-7.97 | $-0.20 | -7.7680 | -3,845.54% |
Financial Statements
| Revenues | $812.03M |
| Benefits Costs and Expenses | $880.12M |
| Costs And Expenses | $766.92M |
| Nonoperating Income/Loss | -$113.20M |
| Operating Expenses | $766.92M |
| Research and Development | $101.58M |
| Other Operating Expenses | $665.34M |
| Operating Income/Loss | $45.11M |
| Income/Loss From Continuing Operations After Tax | -$68.09M |
| Income/Loss From Continuing Operations Before Tax | -$68.09M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$68.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$68.09M |
| Net Income/Loss Available To Common Stockholders, Basic | -$537.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $469.87M |
| Preferred Stock Dividends And Other Adjustments | $469.87M |
| Basic Earnings Per Share | -$3.22 |
| Diluted Earnings Per Share | -$3.22 |
| Basic Average Shares | 167,205,616 |
| Diluted Average Shares | 167,205,616 |
| Assets | $1.13B |
| Current Assets | $997.80M |
| Prepaid Expenses | $19.59M |
| Other Current Assets | $978.21M |
| Noncurrent Assets | $127.86M |
| Fixed Assets | $63.17M |
| Other Non-current Assets | $64.69M |
| Liabilities | $548.36M |
| Current Liabilities | $127.15M |
| Accounts Payable | $39.21M |
| Other Current Liabilities | $87.94M |
| Noncurrent Liabilities | $421.21M |
| Long-term Debt | $378.45M |
| Other Non-current Liabilities | $42.76M |
| Equity | $577.31M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $577.31M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $1.13B |
| Net Cash Flow From Operating Activities | $83.16M |
| Net Cash Flow From Operating Activities, Continuing | $83.16M |
| Net Cash Flow From Investing Activities | -$16.26M |
| Net Cash Flow From Investing Activities, Continuing | -$16.26M |
| Net Cash Flow From Financing Activities | $664.99M |
| Net Cash Flow From Financing Activities, Continuing | $664.99M |
| Net Cash Flow | $731.88M |
| Net Cash Flow, Continuing | $731.88M |
| Comprehensive Income/Loss | -$67.36M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$67.36M |
| Other Comprehensive Income/Loss | -$67.36M |
| Other Comprehensive Income/Loss Attributable To Parent | $698.00K |